Use of Pfizer-BioNTech COVID-19 vaccine: Clinical considerations | Centers for Disease Control and Prevention |
---|---|
Centers for Disease Control and Prevention | Centers for Disease Control and Prevention |
Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera | Information about COVID-19 vaccines for people with allergies |
---|---|
Interim considerations for COVID-19 vaccination of healthcare personnel and long-term care facility residents | Pfizer-BioNTech vaccine: Fact sheet for recipients and caregivers |
Officials discuss COVID-19 vaccine deliveries prioritization criteria | Vaccine Adverse Event Reporting System |
---|---|
FDA takes additional action in fight against COVID-19 by issuing emergency use authorization for second COVID-19 vaccine | COVID-19 vaccines and allergic reactions |